Boerhaave syndrome epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Boerhaave syndrome}}
{{Boerhaave syndrome}}
{{CMG}} {{AE}} {{DM}} {{Ajay}}
{{CMG}} {{AE}} {{DM}} {{Ajay}} {{SHH}}


==Overview==
==Overview==

Revision as of 19:44, 5 February 2018

Boerhaave syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Boerhaave syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Boerhaave syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Boerhaave syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Boerhaave syndrome epidemiology and demographics

CDC on Boerhaave syndrome epidemiology and demographics

Boerhaave syndrome epidemiology and demographics in the news

Blogs on Boerhaave syndrome epidemiology and demographics

Directions to Hospitals Treating Boerhaave syndrome

Risk calculators and risk factors for Boerhaave syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamed Diab, MD [2] Ajay Gade MD[3]] Shaghayegh Habibi, M.D.[4]

Overview

The incidence of Boerhaave syndrome is 3.1 per 100,000 individuals. Boerhaave syndrome accounts for 15% of all cases of spontaneous perforations of the esophagus. Boerhaave syndrome is most frequently seen among patients 50-70 years of age, and least susceptible to age group is 1-17 years. Boerhaave syndrome occurs more in men than women by a ratios ranging from 2:1 to 5:1.

Epidemiology and Demographics

Incidence

The incidence of Boerhaave syndrome syndrome is 3.1 per 100,000 individuals.[1]

Boerhaave syndrome accounts for 15% of all cases of spontaneous perforations of the esophagus.[2]

Age

Boerhaave syndrome is most frequently seen among patients 50-70 years of age, and least susceptible to age group is 1-17 years.

Gender

Boerhaave syndrome occurs more in men than women by a ratios ranging from 2:1 to 5:1.

References

  1. Vidarsdottir H, Blondal S, Alfredsson H, Geirsson A, Gudbjartsson T (2010). "Oesophageal perforations in Iceland: a whole population study on incidence, aetiology and surgical outcome". Thorac Cardiovasc Surg. 58 (8): 476–80. doi:10.1055/s-0030-1250347. PMID 21110271.
  2. Brinster CJ, Singhal S, Lee L, Marshall MB, Kaiser LR, Kucharczuk JC (2004). "Evolving options in the management of esophageal perforation". Ann. Thorac. Surg. 77 (4): 1475–83. doi:10.1016/j.athoracsur.2003.08.037. PMID 15063302.

Template:WH Template:WS